Selected research
Industry Research
Propofol Drug Industry Research Report 2026
Market perspective
The global Propofol Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Propofol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Propofol Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Propofol Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Propofol Drug include Xi’an Libang Pharmaceutical, Sichuan Kelun Pharmaceutical, Jiangsu Yingke Biopharmaceutical, Guangdong Jiabo Pharmaceutical, Jiangsu Nhwa Pharmaceutical, Beijing Sciecure Pharmaceutical, Sichuan Biokin Pharmaceutical, Wellona Pharma and Rusoma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Propofol Drug market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Propofol Drug Market by Company
Xi’an Libang Pharmaceutical
Sichuan Kelun Pharmaceutical
Jiangsu Yingke Biopharmaceutical
Guangdong Jiabo Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Beijing Sciecure Pharmaceutical
Sichuan Biokin Pharmaceutical
Wellona Pharma
Rusoma
Pfizer
NEON
Fresenius Kabi
Flagship Biotech
Dr. Reddy's Laboratories
Centurion Healthcare
B. Braun
Aspen Pharma
Propofol Drug Segment by Type
50 mL
20 mL
100 mL
10 mL
Propofol Drug Segment by Application
Mechanical Ventilation
General Anesthesia
Medical Procedures Sedation
Other
Propofol Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Propofol Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Propofol Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Propofol Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Propofol Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50 mL
- 20 mL
- 100 mL
- 10 mL
Applications
- Mechanical Ventilation
- General Anesthesia
- Medical Procedures Sedation
- Other
Companies covered
- Xi’an Libang Pharmaceutical
- Sichuan Kelun Pharmaceutical
- Jiangsu Yingke Biopharmaceutical
- Guangdong Jiabo Pharmaceutical
- Jiangsu Nhwa Pharmaceutical
- Beijing Sciecure Pharmaceutical
- Sichuan Biokin Pharmaceutical
- Wellona Pharma
- Rusoma
- Pfizer
- NEON
- Fresenius Kabi
- Flagship Biotech
- Dr. Reddy's Laboratories
- Centurion Healthcare
- B. Braun
- Aspen Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Propofol Drug Market Size (2021-2032)
- 2.2.2 Global Propofol Drug Sales (2021-2032)
- 2.2.3 Global Propofol Drug Market Average Price (2021-2032)
- 2.3 Propofol Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50 mL
- 2.3.3 20 mL
- 2.3.4 100 mL
- 2.3.5 10 mL
- 2.4 Propofol Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Mechanical Ventilation
- 2.4.3 General Anesthesia
- 2.4.4 Medical Procedures Sedation
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Propofol Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Propofol Drug Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Propofol Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Propofol Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Propofol Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Propofol Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Propofol Drug, Product Type & Application
- 3.8 Global Manufacturers of Propofol Drug, Established Date
- 3.9 Global Propofol Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Xi’an Libang Pharmaceutical
- 4.1.1 Xi’an Libang Pharmaceutical Company Information
- 4.1.2 Xi’an Libang Pharmaceutical Business Overview
- 4.1.3 Xi’an Libang Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Xi’an Libang Pharmaceutical Propofol Drug Product Portfolio
- 4.1.5 Xi’an Libang Pharmaceutical Recent Developments
- 4.2 Sichuan Kelun Pharmaceutical
- 4.2.1 Sichuan Kelun Pharmaceutical Company Information
- 4.2.2 Sichuan Kelun Pharmaceutical Business Overview
- 4.2.3 Sichuan Kelun Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sichuan Kelun Pharmaceutical Propofol Drug Product Portfolio
- 4.2.5 Sichuan Kelun Pharmaceutical Recent Developments
- 4.3 Jiangsu Yingke Biopharmaceutical
- 4.3.1 Jiangsu Yingke Biopharmaceutical Company Information
- 4.3.2 Jiangsu Yingke Biopharmaceutical Business Overview
- 4.3.3 Jiangsu Yingke Biopharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangsu Yingke Biopharmaceutical Propofol Drug Product Portfolio
- 4.3.5 Jiangsu Yingke Biopharmaceutical Recent Developments
- 4.4 Guangdong Jiabo Pharmaceutical
- 4.4.1 Guangdong Jiabo Pharmaceutical Company Information
- 4.4.2 Guangdong Jiabo Pharmaceutical Business Overview
- 4.4.3 Guangdong Jiabo Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Guangdong Jiabo Pharmaceutical Propofol Drug Product Portfolio
- 4.4.5 Guangdong Jiabo Pharmaceutical Recent Developments
- 4.5 Jiangsu Nhwa Pharmaceutical
- 4.5.1 Jiangsu Nhwa Pharmaceutical Company Information
- 4.5.2 Jiangsu Nhwa Pharmaceutical Business Overview
- 4.5.3 Jiangsu Nhwa Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jiangsu Nhwa Pharmaceutical Propofol Drug Product Portfolio
- 4.5.5 Jiangsu Nhwa Pharmaceutical Recent Developments
- 4.6 Beijing Sciecure Pharmaceutical
- 4.6.1 Beijing Sciecure Pharmaceutical Company Information
- 4.6.2 Beijing Sciecure Pharmaceutical Business Overview
- 4.6.3 Beijing Sciecure Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Beijing Sciecure Pharmaceutical Propofol Drug Product Portfolio
- 4.6.5 Beijing Sciecure Pharmaceutical Recent Developments
- 4.7 Sichuan Biokin Pharmaceutical
- 4.7.1 Sichuan Biokin Pharmaceutical Company Information
- 4.7.2 Sichuan Biokin Pharmaceutical Business Overview
- 4.7.3 Sichuan Biokin Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sichuan Biokin Pharmaceutical Propofol Drug Product Portfolio
- 4.7.5 Sichuan Biokin Pharmaceutical Recent Developments
- 4.8 Wellona Pharma
- 4.8.1 Wellona Pharma Company Information
- 4.8.2 Wellona Pharma Business Overview
- 4.8.3 Wellona Pharma Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Wellona Pharma Propofol Drug Product Portfolio
- 4.8.5 Wellona Pharma Recent Developments
- 4.9 Rusoma
- 4.9.1 Rusoma Company Information
- 4.9.2 Rusoma Business Overview
- 4.9.3 Rusoma Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Rusoma Propofol Drug Product Portfolio
- 4.9.5 Rusoma Recent Developments
- 4.10 Pfizer
- 4.10.1 Pfizer Company Information
- 4.10.2 Pfizer Business Overview
- 4.10.3 Pfizer Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Propofol Drug Product Portfolio
- 4.10.5 Pfizer Recent Developments
- 4.11 NEON
- 4.11.1 NEON Company Information
- 4.11.2 NEON Business Overview
- 4.11.3 NEON Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 NEON Propofol Drug Product Portfolio
- 4.11.5 NEON Recent Developments
- 4.12 Fresenius Kabi
- 4.12.1 Fresenius Kabi Company Information
- 4.12.2 Fresenius Kabi Business Overview
- 4.12.3 Fresenius Kabi Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Fresenius Kabi Propofol Drug Product Portfolio
- 4.12.5 Fresenius Kabi Recent Developments
- 4.13 Flagship Biotech
- 4.13.1 Flagship Biotech Company Information
- 4.13.2 Flagship Biotech Business Overview
- 4.13.3 Flagship Biotech Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Flagship Biotech Propofol Drug Product Portfolio
- 4.13.5 Flagship Biotech Recent Developments
- 4.14 Dr. Reddy's Laboratories
- 4.14.1 Dr. Reddy's Laboratories Company Information
- 4.14.2 Dr. Reddy's Laboratories Business Overview
- 4.14.3 Dr. Reddy's Laboratories Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Dr. Reddy's Laboratories Propofol Drug Product Portfolio
- 4.14.5 Dr. Reddy's Laboratories Recent Developments
- 4.15 Centurion Healthcare
- 4.15.1 Centurion Healthcare Company Information
- 4.15.2 Centurion Healthcare Business Overview
- 4.15.3 Centurion Healthcare Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Centurion Healthcare Propofol Drug Product Portfolio
- 4.15.5 Centurion Healthcare Recent Developments
- 4.16 B. Braun
- 4.16.1 B. Braun Company Information
- 4.16.2 B. Braun Business Overview
- 4.16.3 B. Braun Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 B. Braun Propofol Drug Product Portfolio
- 4.16.5 B. Braun Recent Developments
- 4.17 Aspen Pharma
- 4.17.1 Aspen Pharma Company Information
- 4.17.2 Aspen Pharma Business Overview
- 4.17.3 Aspen Pharma Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Aspen Pharma Propofol Drug Product Portfolio
- 4.17.5 Aspen Pharma Recent Developments
5 Global Propofol Drug Market Scenario by Region
- 5.1 Global Propofol Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Propofol Drug Sales by Region: 2021-2032
- 5.2.1 Global Propofol Drug Sales by Region: 2021-2026
- 5.2.2 Global Propofol Drug Sales by Region: 2027-2032
- 5.3 Global Propofol Drug Revenue by Region: 2021-2032
- 5.3.1 Global Propofol Drug Revenue by Region: 2021-2026
- 5.3.2 Global Propofol Drug Revenue by Region: 2027-2032
- 5.4 North America Propofol Drug Market Facts & Figures by Country
- 5.4.1 North America Propofol Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Propofol Drug Sales by Country (2021-2032)
- 5.4.3 North America Propofol Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Propofol Drug Market Facts & Figures by Country
- 5.5.1 Europe Propofol Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Propofol Drug Sales by Country (2021-2032)
- 5.5.3 Europe Propofol Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Propofol Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Propofol Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Propofol Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Propofol Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Propofol Drug Market Facts & Figures by Country
- 5.7.1 South America Propofol Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Propofol Drug Sales by Country (2021-2032)
- 5.7.3 South America Propofol Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Propofol Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Propofol Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Propofol Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Propofol Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Propofol Drug Sales by Type (2021-2032)
- 6.1.1 Global Propofol Drug Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Propofol Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Propofol Drug Revenue by Type (2021-2032)
- 6.2.1 Global Propofol Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Propofol Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Propofol Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Propofol Drug Sales by Application (2021-2032)
- 7.1.1 Global Propofol Drug Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Propofol Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Propofol Drug Revenue by Application (2021-2032)
- 7.2.1 Global Propofol Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Propofol Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Propofol Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Propofol Drug Value Chain Analysis
- 8.1.1 Propofol Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Propofol Drug Production Mode & Process
- 8.2 Propofol Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Propofol Drug Distributors
- 8.2.3 Propofol Drug Customers
9 Global Propofol Drug Analyzing Market Dynamics
- 9.1 Propofol Drug Industry Trends
- 9.2 Propofol Drug Industry Drivers
- 9.3 Propofol Drug Industry Opportunities and Challenges
- 9.4 Propofol Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst